Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 6/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.41 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22310514 | 0.88 | GPR119 (0.41) | RAB9AGPR119 | |
| SCHEMBL32685392 | 0.85 | NR1H2 (0.43) | HCRTR1HCRTR2SPHK2PDK2SCN9A | |
| SCHEMBL22311264 | 0.85 | NR1H2 (0.43) | HCRTR1HCRTR2SPHK2PDK2SCN9A | |
| SCHEMBL32685389 | 0.85 | NR1H2 (0.43) | HCRTR1HCRTR2SPHK2PDK2SCN9A | |
| SCHEMBL22311260 | 0.85 | NR1H2 (0.43) | HCRTR1HCRTR2SPHK2PDK2SCN9A | |
| SCHEMBL22311067 | 0.85 | NR1H2 (0.43) | HCRTR1HCRTR2SPHK2PDK2SCN9A | |
| SCHEMBL22311058 | 0.85 | NR1H2 (0.43) | HCRTR1HCRTR2SPHK2PDK2SCN9A | |
| SCHEMBL20060883 | 0.85 | GPR119 (0.38) | GPR119 | |
| SCHEMBL20060927 | 0.83 | GPR119 (0.47) | PDK2GPR119 | |
| SCHEMBL20061055 | 0.83 | GPR119 (0.47) | PDK2GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018068295-A1 | ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME CORP. (US) | 2018-04-19 | — | — | WO | disclosed |
| WO-2018071317-A1 | ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2018-04-19 | — | — | WO | disclosed |